Gsno Therapeutics, Inc.

Biotechnology company · Shelton, Washington, United States

Gsno Therapeutics, Inc. is a biotechnology company headquartered in Shelton, Washington, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $279,654 in total, most recently in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Gsno Therapeutics at a glance

Typebiotechnology company

HeadquartersShelton, Washington, United States

Employees (self-reported, 2023)3

What does Gsno Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $279,654 in total (2023). NIH funding came from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Eye Institute.

Frequently asked questions about Gsno Therapeutics

Where is Gsno Therapeutics headquartered?

Gsno Therapeutics, Inc. is headquartered in Shelton, Washington, United States.

What does Gsno Therapeutics do?

Gsno Therapeutics, Inc. is a biotechnology company.

Similar companies

Intensity Therapeutics, Inc.Shelton, Connecticut, United States
MycoMedica Life Sciences, PBCShelton, Washington, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Cognition Therapeutics IncPurchase, New York, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences